Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Diabetic Foot Ulcer Treatment Market, by Product (Advance Wound Dressings, Skin Substitutes, Growth Factors, Negative Pressure Wound Therapy Devices, and Other Devices), by Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), by End User (Hospitals, Specialty Clinics, Long Term Care Centers, and Ambulatory Surgical Center), and by Region (North America, Latin America, Europe, Asia Pacific,) is estimated to be valued at US$  6,411.3 Mn in 2021 and is expected to exhibit a CAGR of 10.2% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Key players in the market are focusing on inorganic growth strategies such as acquisitions, which is expected to propel growth of the global diabetic foot treatment market over the forecast period. For instance, in July 2018, Mölnlycke a world leader medical solutions company, acquired Germany-based wound care products company, SastoMed GmbH to expand its product offering to help patients and healthcare professionals to accelerate the wound healing process and treating chronic wound such as diabetic foot ulcer.

Global Diabetic Foot Ulcer Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Throughout 2020, the COVID-19 pandemic has had a significant impact on the care of non-communicable diseases across the world, and diabetes is no exception. Whereas many branches of medicine have adapted to telemedicine, this is difficult and challenging for the diabetic foot, which often requires “hands-on” treatment. Widespread publicity of the COVID-19 pandemic has alerted those with diabetes foot ulcers to realize that should they be admitted to the hospital, the risk of poor outcomes is higher than those without diabetes. Thus, many people with diabetes foot ulcers have been terrified to attend hospital clinics as they quite rightly perceive that the hospital is likely to be occupied by many patients with active COVID-19 disease. This perceived and, in many ways, realistic fear has led to a reduced attendance rate that has been observed in many hospital outpatient clinics. These factor will hamper the market growth in the forecast period.

Browse 27 Market Data Tables and 31 Figures spread through 156 Pages and in-depth TOC on “Global Diabetic Foot Ulcer Treatment Market.”-  Forecast to 2028, Global Diabetic Foot Ulcer Treatment Market, by Product (Advance Wound Dressings, Skin Substitutes, Growth Factors, Negative Pressure Wound Therapy Devices, and Other Devices), by Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), by End User (Hospitals, Specialty Clinics, Long Term Care Centers, and Ambulatory Surgical Center), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/diabetic-foot-ulcers-treatment-market-1357

Moreover, increasing product launches and regulatory approvals are also expected to aid in growth of the global diabetic foot ulcers treatment market over the forecast period. For instance, in May 2019, UPM, a company delivering renewable and responsible solutions and innovate for a future beyond fossils across six business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, and UPM Plywood., launched a new advanced wound care product for the European market. FibDex is the first wound dressing created from wood-based nanofibrillar cellulose to and awarded a CE mark.

Key Takeaways of the Global Diabetic Foot Ulcer Treatment Market:

  • The global diabetic foot ulcers treatment is expected to exhibit a CAGR of 10.2% during the forecast period due to increasing . Alcohol abuse in people with diabetes increases the risk for high blood pressure, heart disease, eye problems, and nerve damage. Alcohol and tobacco play a role in the development of foot ulcers. For instance, according to the World Health Organization, 1.337 billion people smoked tobacco worldwide in 2018.
  • Among end user, hospitals segment is estimated to hold largest market share in the global diabetic foot ulcer treatment market over the forecast period. Increasing hospitalizations for the treatment of diabetes foot ulcers is expected to drive growth of the segment. For instance, according to the Diabetes Australia, every year there are 10,000 hospital admissions in Australia for diabetes-related foot ulcers.
  • Among regions, . Increasing the prevalence of diabetic foot ulcer in U.S is expected to drive the North America diabetic foot ulcers treatment market over the forecast period. For instance,
  • Major players operating in the global diabetic foot ulcer treatment market include 3M Healthcare, B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, and Molnlycke Health Care AB.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner